You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Campath

Showing 1 - 25 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

Completed
Has Results
  • Hodgkin Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Campath
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022

Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

Completed
Has Results
  • Lymphoma, T-Cell
  • Lymphoma, Extranodal NK-T-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022

Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)

Completed
Has Results
  • Renal Transplant
  • Arm 1 Everolimus/Reduced dose tacrolimus
  • Toledo, Ohio
    University of Toledo, Health Science Campus
May 2, 2022

Allogeneic Hematopoietic Cell Transplantation Trial (Alemtuzumab)

Not yet recruiting
  • Allogeneic Hematopoietic Cell Transplantation
  • (no location specified)
Aug 12, 2022

Predict T Cell Chimerism After MSD SCT for SCD?

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab Injection [Campath]
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jun 20, 2023

Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

Recruiting
  • Non Malignant Diseases
  • +2 more
  • RIC: Distal Campath
  • +2 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 8, 2022

Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

Completed
Has Results
  • Kidney Transplantation
  • +2 more
  • London, United Kingdom
    West London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
Has Results
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)

Completed
Has Results
  • Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 2, 2021

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)

Active, not recruiting
  • Sickle Cell Disease
  • Hackensack, New Jersey
    Hackensack University Medical Center
Feb 4, 2022

Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

Completed
Has Results
  • Sickle Cell Disease
  • Beta Thalassemia-Major
  • alemtuzumab (Campath IH)
  • +6 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Jul 30, 2021

Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

Completed
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Paris, France
    Hôpital Necker-Enfants Malades
Apr 13, 2021

Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

Completed
Has Results
  • Inherited Immune Deficiencies
  • Campath 1H
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Disorder Related to Renal Transplantation Trial in Madison (Campath-1H)

Terminated
Has Results
  • Disorder Related to Renal Transplantation
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Aug 31, 2020

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022